community Here's why Pryiltamide "failed" phase 3 trials and marketed as a cosmetic
KX-826 failed Phase III trials due to high placebo effects, patient compliance issues, COVID-19 side effects, and detection method deviations. KX-826 is now marketed as a cosmetic and approved for combination with Minoxidil.